Interview of Philippe Pouletty by Hedwige Chevrillon in "Le Grand Journal de l'Éco" on BFM Business TV
"Radically innovative science solves environment and health issues"
Merck KGaA entrusts secretive startup with a mid-stage cancer drug targeting master signaling pathway
A secretive French biotech has imported a drug from Germany’s Merck KGaA that will leapfrog the small company right into mid-stage testing...
Could HIV be cured by tackling ‘bumpy’ CD4 cells? France’s Diaccurate wants to find out
Finding a functional cure to HIV is one of the biggest challenges in modern medicine...
Carmat sells its artificial heart for the first time in Italy
The autonomous bioprosthesis created by the French firm has been implanted on a patient in Naples.
Holistick raises $5M to boost preclinical development of PFO closure device
Discussion of Abivax Clinical Program involving Covid-19, Ulcerative Colitis, Crohn’s Disease and more
Hartmut Ehrlich and Philippe Pouletty discuss Abivax Pipeline of Clinical Programs involving Covid-19, Ulcerative Colitis, Crohn’s Disease...
Centers for Medicare & Medicaid Services (CMS) grant transitional pass-through (TPT) payment for Stryker's SpineJack® System
CMS announced the SpineJack implantable fracture reduction system qualified for the TPT payment as part of the 2021 Medicare Payment System.
Abivax Turns Away Suitors as Lead Drug Starts Covid-19 Tests
Abivax, the French biotech embarking on tests of its lead experimental medicine for Covid-19, has turned away several suitors in recent months.
MEDEOR, Truffle Capital's new BioMedTech Fund, qualified by institutional investors through the Tibi committee
Medeor is among the 24 new funds qualified by the committee of institutional investors set up following the Tibi report.
Philippe Pouletty and Hartmut J. Ehrlich - ABIVAX - Covid-19 Quarantine
WCBS NewsRadio 880: CEO RADIO
Investors Search for Promising Covid Cures
The race to develop vaccines and treatments to build immunity to the novel coronavirus ...
Abivax Stock Soars as French Regulator Approves Testing of a Drug to Treat Covid-19
The French biotech company Abivax announced Thursday that it had received clearance from French regulators to begin a 1,000 patient trial ...
Abivax to evaluate anti-inflammatory effects of ABX464 in large-scale COVID-19 trial
Abivax SA has rejected an acquisition offer in order to pursue a phase IIb/III trial of its lead anti-inflammatory drug ABX464 ...
Pharnext, a Truffle Capital creation, fights Covid-19
How to find existing effective drugs, against coronavirus
Bloomberg : Diaccurate Scientists show how HIV disables Immune System
Truffle Capital Raises € 250m Fund to Launch Life Science Startups
The French VC firm Truffle Capital has closed a fund worth € 250m with a mission to nurture companies specializing in medical devices
Truffle Capital reports outstanding 2020 stock market performance for its listed BioMedTech portfolio companies
Three companies founded or co-founded by Truffle represent 30% of the total valuation of the highest BioMedTech market caps of Euronext Paris...
Great article about Abivax : what makes it a unique candidate to treat Covid-19
In addition to its exciting results in ulcerative colitis...